Standout Papers

Olezarsen for Hypertriglyceridemia in Patient... 2021 2026 2022 2024120
  1. Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk (2024)
    Brian A. Bergmark, Nicholas Marston et al. New England Journal of Medicine
  2. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis (2021)
    Marc S. Sabatine, Brian A. Bergmark et al. The Lancet

Immediate Impact

56 standout
Sub-graph 1 of 21

Citing Papers

New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
2024 Standout
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
3 intermediate papers

Works of Brian A. Bergmark being referenced

Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
2024 Standout
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction
2019

Author Peers

Author Last Decade Papers Cites
Brian A. Bergmark 466 494 164 174 68 1.1k
Garima Arora 712 284 81 212 76 1.3k
Galen Cook‐Wiens 510 386 390 116 86 1.4k
John Cahill 486 289 147 177 66 1.2k
Patrick Sulzgruber 533 217 70 156 103 1.1k
Zdenko Sonicki 236 309 45 134 68 964
Srikanth Vallurupalli 911 373 118 140 81 1.4k
Naveen Garg 292 181 64 250 61 994
Farzad Masoudkabir 443 154 96 168 88 924
Mario D’Souza 354 238 252 196 53 1.3k
Dong‐Soo Kim 618 489 238 87 88 1.2k

All Works

Loading papers...

Rankless by CCL
2026